Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Net Income
Yield10 Bioscience Inc
Net Income Peer Comparison
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Net Income
-$14.5m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
7%
|
|
Abbvie Inc
NYSE:ABBV
|
Net Income
$4.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Income
$3.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Income
$3.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Income
$3.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
26%
|
See Also
What is Yield10 Bioscience Inc's Net Income?
Net Income
-14.5m
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Net Income amounts to -14.5m USD.
What is Yield10 Bioscience Inc's Net Income growth rate?
Net Income CAGR 10Y
7%
Over the last year, the Net Income growth was -7%. The average annual Net Income growth rates for Yield10 Bioscience Inc have been -12% over the past three years , -10% over the past five years , and 7% over the past ten years .